Formerly Somite AI, the rebranded company aims to broaden the regenerative medicine landscape by building AI models that ...
Researchers say discoveries could expand the CRISPR toolbox and lead to more efficient, rapid diagnostic tools for detecting COVID-19, influenza, and RSV.